RECORD // Company

Nanoviricides, Inc.

Built 2026-11-22T03:53:25Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • NANOVIRICIDES, INC. · legal entity in this company's GLEIF ownership tree (LEI 5493003CK9Y2H0OORR73)
SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001104659-26-128532

ItemValuePeriodFormFiledAccessionReport
Revenue$03 months ended 2026-09-3010-Q2026-11-160001104659-26-1285322026-11-22 03:53 UTCReport an error
Net income (loss)$-5,742,9363 months ended 2026-09-3010-Q2026-11-160001104659-26-1285322026-11-22 03:53 UTCReport an error
Cash and cash equivalents$2,575,227at 2026-09-3010-Q2026-11-160001104659-26-1285322026-11-22 03:53 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001379006
Ticker
NNVC
EIN
760674577
CUSIP
630087302
Record ID
sx:sec:0001379006

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

31 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
State of incorporationDE2026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
Fiscal year end (MMDD)06302026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
Business address1 CONTROLS DRIVE, SHELTON, CT, 064842026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
ExchangesNYSE2026-11-17SEC EDGAR company profile2026-11-22 03:53 UTCReport an error
Revenue (fiscal year ended 2026-06-30)$02026-06-3010-K, XBRL RevenueFromContractWithCustomerIncludingAssessedTax2026-11-22 03:53 UTCReport an error
Net income (loss) (fiscal year ended 2026-06-30)$-8,218,5092026-06-3010-K, XBRL NetIncomeLoss2026-11-22 03:53 UTCReport an error
Total assets (at 2026-06-30)$9,873,6142026-06-3010-K, XBRL Assets2026-11-22 03:53 UTCReport an error
Stockholders' equity (at 2026-06-30)$8,682,8902026-06-3010-K, XBRL StockholdersEquity2026-11-22 03:53 UTCReport an error
Cash and cash equivalents (at 2026-06-30)$2,794,1102026-06-3010-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:53 UTCReport an error
Operating cash flow (fiscal year ended 2026-06-30)$-7,696,0152026-06-3010-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:53 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2026-06-30)$84,3172026-06-3010-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:53 UTCReport an error
Form D total offering amount (D filed 2026-02-25)$6,000,0002026-02-25D2026-11-22 03:53 UTCReport an error
Form D total amount sold (D filed 2026-02-25)$6,000,0002026-02-25D2026-11-22 03:53 UTCReport an error
Form D industry groupPharmaceuticals2026-02-25D2026-11-22 03:53 UTCReport an error
Form D revenue rangeDecline to Disclose2026-02-25D2026-11-22 03:53 UTCReport an error
Form D date of first sale2025-11-122026-02-25D2026-11-22 03:53 UTCReport an error
8-K Item 5.02 (filed 2026-09-29)Compensatory Arrangements of Certain Officers. Extension Employment Agreement - Anil Diwan On September 25, 2026, NanoViricides, Inc. (the “Registrant”) entered into an Extension Agreement effective July 1, 2026 (the “Diwan Extension”) of the Employment Agreement with Dr. Anil R. Diwan entered into on July 1, 2018 (the “Diwan Employment Agreement”) to continue to serve as the President of the Registrant, effective July 1, 2026. The Extension provides that Dr. Diwan will continue to serve as the Registrant’s President until June 30, 2027 at a base annual base salary of $400,000. Dr. Diwan shall be entitled to participate in all fringe benefits the Registrant provides for its employees…2026-09-29SEC EDGAR 8-K 0001104659-26-111952 (text as filed, excerpt)2026-11-22 03:53 UTCReport an error
8-K Item 1.01 (filed 2026-07-30)Entry into a Material Definitive Agreement. Securities Purchase Agreement On July 24, 2026, NanoViricides, Inc. (the “Company”) and a certain purchaser (the “Investor”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company agreed to sell and issue to the Investor in a registered direct offering (the “Offering”): (i) 2,416,339 shares of common stock, par value $0.00001 per share (the “Common Stock”), at an offering price of $1.53 per share, (ii) pre-funded warrants to purchase up to 100,000 shares of Common Stock, at an offering price of $1.52999 per pre-funded warrant (the “Pre-Funded Warrants”), and (iii) accompanying common…2026-07-30SEC EDGAR 8-K 0001104659-26-088393 (text as filed, excerpt)2026-11-22 03:53 UTCReport an error
8-K Item 8.01 (filed 2026-07-30)Other Events. On July 24, 2026, the Company issued a press release announcing the Offering. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 8.01 by reference.2026-07-30SEC EDGAR 8-K 0001104659-26-088393 (text as filed, excerpt)2026-11-22 03:53 UTCReport an error
Largest institutional holder #1 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$1,268,6522026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #2 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$298,1782026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #3 (13F as filed): Connective Capital Management, LLC$255,5992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #4 (13F as filed): BlackRock, Inc.$219,0792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #5 (13F as filed): VANGUARD FIDUCIARY TRUST CO$182,0542026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #6 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$177,4682026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #7 (13F as filed): Miller Financial Services LLC$154,5602026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #8 (13F as filed): UBS Group AG$137,0772026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #9 (13F as filed): SUSQUEHANNA INTERNATIONAL GROUP, LLP$83,6502026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error
Largest institutional holder #10 (13F as filed): STATE STREET CORP$74,8042026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:53 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.